Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c

Citius Pharmaceuticals (NASDAQ: CTXR) reported Q2 EPS of ($0.11).

For earnings history and earnings-related data on Citius Pharmaceuticals (CTXR) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• CAVA Group Inc (CAVA) PT Lowered to $95 at Guggenheim
• Coherent (COHR) PT Raised to $420 at Needham